0001415889-24-007083.txt : 20240306
0001415889-24-007083.hdr.sgml : 20240306
20240306173737
ACCESSION NUMBER: 0001415889-24-007083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240306
DATE AS OF CHANGE: 20240306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Sanj K
CENTRAL INDEX KEY: 0001532218
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 24727252
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
form4-03062024_100330.xml
X0508
4
2024-03-04
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001532218
Patel Sanj K
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM 11
BERMUDA
true
true
false
false
CHAIRMAN & CEO
1
Class A Common Share
2024-03-04
4
S
0
9406
21.31
D
73930
I
Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Class A Common Share
2024-03-04
4
S
0
3336
22
D
70594
I
Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Class A Common Share
2024-03-06
4
S
0
5582
21
D
65012
I
Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Class A Common Share
109795
I
Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016
Class A Common Share
52516
D
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $21.00 and $21.785. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2024-03-06